Viking Therapeutics (VKTX)
(Delayed Data from NSDQ)
$61.93 USD
-3.08 (-4.74%)
Updated Sep 24, 2024 03:59 PM ET
After-Market: $61.93 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/23/2024
Time: -- |
9/2024 | $-0.24 | -7.00% |
Earnings Summary
For their last quarter, Viking Therapeutics (VKTX) reported earnings of -$0.20 per share, beating the Zacks Consensus Estimate of $-0.26 per share. This reflects a positive earnings surprise of 23.08%. Look out for VKTX's next earnings release expected on October 23, 2024. For the next earning release, we expect the company to report earnings of -$0.24 per share, reflecting a year-over-year decrease of 4.35%.
Earnings History
Price & Consensus
Zacks News for VKTX
NVO Stock Loses Around $29B in 3 Months: Buy the Dip or Steer Clear?
VKTX: What are Zacks experts saying now?
Zacks Private Portfolio Services